GlobalCapital Securitization, is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

SecuritizationABS

Oxford brings rare venture capital-backed ABS

Pharma,

Venture capital firm Oxford Finance is issuing a $312.8m securitization backed by loans made to life sciences and healthcare companies, the largest deal from the issuer and its fastest return to market since issuing its previous deal.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login